We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Vanda Schizophrenia Drug Patentable, Fed. Circ. Says

Law360 (April 13, 2018, 11:17 PM EDT) -- The Federal Circuit on Friday upheld a patent covering Vanda Pharmaceuticals Inc.’s schizophrenia drug Fanapt, finding it met the U.S. Supreme Court’s Mayo standard by outlining a specific method of using...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

September 26, 2016


Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

September 26, 2016

Law Firms

Companies

Government Agencies

Patents

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.